Poslat dál
RSS
google +
Verze pro tisk

Novinky (Drogy)

This section on health in the EU has been created as a trustworthy gateway to a wide range of information and data on health-related issues and activities at both European, national and international level. The content is produced by the European Commission, the Member States of the EU and the European Economic Area (EEA), plus EU candidate countries; by international organisations; and by pan-European non-governmental organisations in the area of public health.

EMCDDA underlines growing importance of effective treatment for cannabis use    europa.eu

Providing effective treatment for those with cannabis use disorders is likely to become a matter of growing importance in European drug policy. This is according to the EU drugs agency (EMCDDA) today[...]

Coming soon: European Drug Report 2015    europa.eu

(Lisbon, 15.04.2015) What are the latest drug market trends and what are the factors driving them? What are the most recent developments in drug prevention, treatment and policy? How many new drugs w[...]

New psychoactive substances in Europe - Just Published - EU Bookshop    europa.eu

An update from the EU Early Warning System, March 2015[...]

Parkinson's Disease Severity and Use of Dopaminergic Medications    epda.eu.com

The outcomes measured at the beginning of the study showed lower disease burden for participants on initial DA monotherapy compared to those taking combined LD and DA therapy after controlling for ag[...]

Just published: Pregnancy and opioid use: strategies for treatment    europa.eu

Illicit opioid consumption during pregnancy brings with it the risk of an increase in obstetric complications for the mother and a range of potential dangers for the child, both before and after birt[...]

EMCDDA presents latest update on ‘new drugs’ from EU Early Warning System    europa.eu

(Lisbon/Vienna, 09.03.2015) New psychoactive substances (NPS or `new drugs') were detected in the European Union last year at the rate of around two per week, according to an update issued today by t[...]

Just published: Poster: new psychoactive substances in Europe    europa.eu

Poster/wall-chart to accompany the EMCDDA publication: New psychoactive substances in Europe - an update from the EU Early Warning System.[...]

Just published: New psychoactive substances in Europe    europa.eu

This short report provides an update on new psychoactive substances (NPS) in Europe for 2014. It highlights recent developments, including the growth of the market over the past few years, as illustr[...]

Just published: Prevention of infectious diseases among people who inject drugs in some Western Balkan countries    europa.eu

This report was prepared based on materials of the Reitox Academy `Prevention of infectious diseases among people who inject drugs in some Western Balkan countries which took place on 29-30 October 2[...]

Just published: Prevention of infectious diseases among people who inject drugs in some Western Balkan countries    europa.eu

This report was prepared based on materials of the Reitox Academy `Prevention of infectious diseases among people who inject drugs in some Western Balkan countries which took place on 29-30 October 2[...]

Just published: Wound botulism in people who inject heroin in Norway and the United Kingdom    europa.eu

The European Centre for Disease Prevention and Control (ECDC) and the EMCDDA released a joint risk assessment on wound botulism among people who inject heroin in Norway and the United Kingdom in Febr[...]

Just published: EMCDDA internal statistics code of practice    europa.eu

One of the three core principles of the EMCDDA 2013-15 strategy is a commitment to efficiency. This is to be achieved, among others, via an improved quality assurance framework for the statistical pr[...]

Just published: Work programme 2015    europa.eu

The EMCDDA's 2015 annual work programme sets out the objectives for the final year of the agency's 2013-15 strategy. Among the core principles are: delivering a relevant, timely and responsive analys[...]

New EMCDDA annual work programme published today    europa.eu

The EMCDDA has published today its 2015 annual work programme, adopted by its Management Board on 5 December. The new programme sets out the objectives for the final year of the agency's 2013-15 stra[...]

Just published: Drugnet Europe 89    europa.eu

In this issue: New EMCDDA trendspotter study explores online supply of drugs | EMCDDA scientific paper award 2015 | New review studies the effectiveness of overdose antidote, naloxone | Finland updat[...]

New EMCDDA review studies the effectiveness of overdose antidote, naloxone    europa.eu

Can naloxone provided in the community help reduce the thousands of drug-induced deaths recorded in Europe every year? This is the question explored by the EU drugs agency (EMCDDA) in a new paper rel[...]

Just published: Preventing fatal overdoses: a systematic review of the effectiveness of take-home naloxone    europa.eu

Drug overdose is one of the major causes of death among young people in Europe. This paper considers how naloxone - an effective antidote that can reverse opioid intoxication - combined with training[...]

Disclaimer

The European Commission is solely responsible for information present on EU-level websites, information present in the Portal originated by the Commission. National-level information is provided by the Member States concerned and Member States are solely responsible for the accuracy of the information. Likewise, the European Commission is not responsible for information on non-governmental organisations and international organisations websites. The European Union is committed to user privacy. Read more concerning the Legal Notice.
Further questions can be answered through the Contact page. The Health-EU portal supports principles and measures to increase the credibility of information on the net. It complies with the HONcode standard for trustworthy health information: verify here.